Skip to content
Medical Health Aged Care

World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care

World Stroke Organization 2 mins read
GENEVA--BUSINESS WIRE--

On World Stroke Day, October 29, the World Stroke Organization (WSO) announces the launch of a global coalition aimed at accelerating policy action on stroke—now the second leading cause of death and the third leading cause of disability worldwide.

Over the past three decades, the global burden of stroke has doubled. Stroke's impact is expected to increase by one-third by 2050. This rise could result in 9.7 million annual deaths and a significant increase in those affected by stroke-related disabilities. Beyond the immense human toll, stroke is projected to cost the global economy over USD 1.6 trillion annually by 2050.

“There is a clear misperception of stroke as an unavoidable, age-related condition with limited treatment options,” said WSO President, Professor Jeyaraj Pandian. “Evidence shows that stroke is increasingly affecting younger populations, with 80% of all cases preventable. Expanding access to acute treatments - which only 5% of eligible patients currently access - can transform patient outcomes, while specialist rehabilitation can enhance recovery and social reintegration. Not only is stroke largely preventable, it is treatable and beatable.”

In September 2025, Heads of State, Ministers of Health and Finance, and development stakeholders will convene in New York for the fourth UN High-Level Meeting on Non-Communicable Diseases (NCDs). With only five years remaining to SDG 3.4 on reducing premature mortality from NCDs, this gathering presents a critical opportunity to drive commitment to policy interventions and investment in stroke.

“Around the world we can see the huge gaps in stroke care at every stage in the patient care pathway. Each of these gaps represents enormous potential for progress. Action on stroke really is the key to accelerating progress on health and development goals,” said Prof Sheila Martins, co-Chair of the Coalition. “WSO’s network of global and national experts stand ready to support governments develop and implement stroke care systems that will help reduce their burden of disease.”

The stroke advocacy coalition, comprising health and scientific, patient organizations, and industry leaders, is united in its mission to drive engagement with decision-makers at all levels ahead of the 2025 UN meeting. For details of current members visit https://tinyurl.com/44wbp8pb

Notes for editors

1 The World Stroke Organization is the world’s only global NGO with a sole focus on stroke and in official relations with the UN. It is committed to reducing the global burden of stroke through advancing access to effective prevention, treatment, rehabilitation, and support. WSO is a membership organization and represents over 50,000 stroke experts in every global region. WSO’s 100 Society Members represent international, regional and national scientific, medical and patient organizations.

2 More information on stroke burden and recommendations for policy makers can be found in The Lancet Neurology – WSO Commission on Stroke https://www.thelancet.com/commissions/global-burden-stroke

3 WSO policy recommendations for implementation of effective acute stroke treatment can be found in Time for a Revolution in Stroke Care


Contact details:

For more information, contact the WSO Campaign Manager awiseman@world-stroke.org +44 7940 029444

Media

More from this category

  • Business Company News, Medical Health Aged Care
  • 12/11/2024
  • 10:00
Jane Morgan Management

LTR Pharma Ltd (ASX:LTP) Announces Joint Venture with Leading Men’s Health Group to Launch New Online Healthcare Platform

Sydney, Australia – 12 November 2024 | LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce its new strategic joint venture with the Restorative Sexual Health Clinic Pty Ltd (RSHC), a prominent Australian men’s health group, to launch an online healthcare platform dedicated to men’s health. The platform will provide accessible, comprehensive health services, including medical consultations, therapeutic services, prescription treatments, and integrated health management solutions. Highlights: Strategic Partnership/Joint Venture: The joint venture combines LTR Pharma’s pharmaceutical expertise with RSHC’s clinical experience in the men’s health space to create a digital platform offering discreet and convenient…

  • Contains:
  • Medical Health Aged Care
  • 12/11/2024
  • 07:00
Monash University

The hidden burden of weight stigma in pregnant women and new mums

People with larger bodies commonly face a pervasive, resilient form of social stigma, often facing discrimination in the workplace as well as in educational and healthcare settings. Weight stigma is particularly prevalent across the various stages of pregnancy – from preconception, pregnancy, to the postpartum (PPP) periods – because of societal norms and expectations about weight and weight gain during the reproductive period. This form of sizeism is dangerous, because this discrimination of pregnant women and new mums can lead to negative physical and psychological health outcomes for mother and potentially their child. Now Monash University researchers have developed a…

  • Medical Health Aged Care
  • 11/11/2024
  • 22:11
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise

IDEAYA has exercised the option for an exclusive worldwide license on Biocytogen’s potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody-drug conjugate (BsADC), BCG034 (IDE034) This milestone…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.